The costs of drugs is increasingly becoming an issue in cancer care. The balance of quality and cost raises the issue of cost effectiveness. More presentations at the recent ASCO meeting were about cost effectiveness than ever before. Already, patients may find their care limited by insurance coverage decisions; patient costs continue to be a concern.
Read the full article here